Topics
Glioblastoma | Treatment | Targeted therapy | Glutamate signaling inhibitors
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Glutamate signaling inhibitors
Mastall M, Roth P, Bink A, Fischer
Maranta A, Läubli H, Hottinger AF, Hundsberger T, Migliorini
D, Ochsenbein A, Seystahl K, Imbach L, Hortobagyi T, Held L,
Weller M, Wirsching HG.
A
phase Ib/II randomized, open-label drug repurposing trial of
glutamate signaling inhibitors in combination with
chemoradiotherapy in patients with newly diagnosed glioblastoma:
the GLUGLIO trial protocol.
BMC
Cancer. 2024 Jan
15;24(1):82. doi:
10.1186/s12885-023-11797-z. PMID:
38225589. Interventional
study protocol. ˍ